Portal de Periódicos da CAPES

Myosin Light Chain 2 Into the Mainstream of Cardiac Development and Contractility

2006; Lippincott Williams & Wilkins; Volume: 99; Issue: 3 Linguagem: Inglês

10.1161/01.res.0000236793.88131.dc

1524-4571

Richard L. Moss, Daniel P. Fitzsimons,

Muscle Physiology and Disorders

HomeCirculation ResearchVol. 99, No. 3Myosin Light Chain 2 Into the Mainstream of Cardiac Development and Contractility Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBMyosin Light Chain 2 Into the Mainstream of Cardiac Development and Contractility Richard L. Moss and Daniel P. Fitzsimons Richard L. MossRichard L. Moss From the Department of Physiology, University of Wisconsin School of Medicine and Public Health, Madison. and Daniel P. FitzsimonsDaniel P. Fitzsimons From the Department of Physiology, University of Wisconsin School of Medicine and Public Health, Madison. Originally published4 Aug 2006https://doi.org/10.1161/01.RES.0000236793.88131.dcCirculation Research. 2006;99:225–227Myocardium exhibits a remarkably broad dynamic range of function that is normally well matched to the circulatory load on the heart. Regulation of cardiac contraction is a multifaceted process that is well understood in terms of the activating role of Ca2+ but much less well in terms of modulation by thick filament accessory proteins and by post-translational modification of thick and thin filament proteins.1,2 In this issue of Circulation Research, an elegant study by Fishman and colleagues3 dramatically reinforces the idea that the light chain 2 subunit of myosin (MLC-2) is critically important in myocardium by showing that MLC-2 loss because of mutation abolishes myofibrillar assembly in zebrafish, resulting in embryonic lethality. Earlier work had shown that mutations in MLC-2 account for some cases of hypertrophic cardiomyopathy4 and that phosphorylation of MLC-2 contributes to cardiac pump function,5 but now it is evident that MLC-2 has an obligatory role in development.Cardiac isoforms of myosin II comprise the motor of myocardial contraction and like all members of this family are composed of 6 subunits6: 2 myosin heavy chains of &200 kDa molecular weight, 2 so-called essential light chains (or light chain 1) of &17 kDa, and 2 regulatory light chains (or light chain 2) of >20 kDa. Subfragment 1 of the heavy chain (Figure) comprises the business end of the motor, containing both the nucleotide and actin-binding sites, whereas the light chains wrap around the rod-like extension of subfragment 1 and are believed to function (minimally) as mechanical stabilizers of this part of myosin during force generation and mechanical work performance. This motor is impressive for its efficiency and its reliability and just as much for the dramatic phenotypic consequences of mutations in its various domains, as in human hypertrophic cardiomyopathies.7Download figureDownload PowerPointDiagram of myosin subfragment 1 with light chains bound. Modified from Rayment et al23MLC-2 Tunes Myocardial ContractionAcross species, the enzymatic activities of myosin are well matched to heart rate (see Epstein and Davis8), which is achieved through variations in the ratios of α (faster) and β (slower) myosin heavy chain isoforms expressed in the heart and also species-specific differences in turnover kinetics of these isoforms.6 But tuning of the motor also takes place on a beat-to-beat basis, principally through phosphorylation of MLC-2 or of thick and thin filament accessory proteins as a means to optimize work capacity and energetic efficiency. Work capacity can be varied by regulating the number of cross-bridges binding to actin by controlling the amount of Ca2+ delivered to myoplasm or by controlling myosin turnover kinetics. The rate of myocardial force development increases when [Ca2+] is increased,9 but this does not appear to be caused by acceleration of cross-bridge cycling kinetics, which are invariant with level of activation. Rather, activation dependence of contraction kinetics appears to be a consequence of cooperative binding of cross-bridges to the thin filament.10 At low [Ca2+], thin filaments are partially activated by the binding of Ca2+ to troponin, but once cross-bridges bind, the activation state is enhanced and additional cross-bridges bind. This positive cooperation in cross-bridge binding increases the force at a given [Ca2+] but also slows the rate of force development because of the time taken to recruit additional cross-bridges.Phosphorylation of MLC-2 by myosin light chain kinase11 increases force and accelerates the rate of force development in myocardium12 but slows relaxation13; however, in this case also, the effects on mechanical properties appear to be mediated by changes in the cooperation of cross-bridge binding to actin. Electron microscopy studies have shown that phosphorylation of MLC-2 in isolated thin filaments results in displacement of cross-bridges away from the thick filament, presumably because of electrostatic repulsion between the phosphate group and fixed charge on the surface of the filament.14 In the intact myofilament, MLC-2 phosphorylation would therefore displace cross-bridges to positions closer to actin and thereby increase the likelihood of binding. Such effects are limited to submaximal Ca2+ concentrations,13 suggesting the net effect of the displacement is to speed the cooperative recruitment of cross-bridges to force generating states, which would increase force and the rate of force development. Likewise, slowed rates of relaxation would be a consequence of increased likelihood of cross-bridge re-binding to actin once detached and not a slower rate of detachment.Epstein and Davis4,5,8 have proposed that transmural variations in regulatory light chain phosphorylation contribute to both diastolic and systolic function in the heart. Their finding in rat heart that the outer (epicardial) layers of myocardium are phosphorylated to a greater degree than the innermost layers suggests that there is a transmural gradient in force production, which is greatest in the epicardium. With respect to ejection, they propose that the rightward torsional twist of the heart (when viewed from the base) during systole would result in stretch of endocardium, which in turn would result in a stretch activation of the endocardium. Such a mechanism could be critical to the later stages of ejection, and since the properties of stretch activation vary with [Ca2+],15 this could also be a mechanism for kinetic tuning of the ejection phase.MLC-2 Required for Cardiac MyofibrillogenesisThe article by Rottbauer et al3 in this issue exploits the finding that zebrafish heart expresses a single isoform of cardiac MLC-2 at all stages of development, so that disruption of MLC-2 expression did not lead to compensatory upregulation of another isoform. Earlier work in a murine model showed that ablation of the MLC-2v gene resulted in abnormal myofibrillogenesis and lethality at embryonic day 12.5, leading to the important conclusion that MLC-2v is required for normal myofibrillogenesis in mouse ventricle.16 However, a compensatory increase in the expression of the atrial MLC-2a isoform in the ventricle presumably contributed to the structural and functional phenotypes that were observed in those experiments.16 In the present study, the absence of compensatory expression of an alternate isoform resulted in failure to form thick filaments, even while thin filament assembly was evident. Painstaking control experiments showed that this effect was caused by absence of MLC-2 expression and occurred in a cell autonomous manner. These results show conclusively that MLC-2 is required for thick filament assembly by an as yet unknown mechanism.Interesting PossibilitiesCa2+ Binding by MLC-2Cardiac MLC-2 has a Ca2+/Mg2+ binding17 that could conceivably play a role in myofibrillogenesis. The site has high sequence homology with other high-affinity Ca2+/Mg2+ sites and is located in the amino-terminal region of MLC-2 in close proximity to the serine residue that is phosphorylated by myosin light chain kinase. Because of high levels of Mg2+ in the myoplasm, this site is most likely occupied by Mg2+ when the muscle is relaxed and appears to exchange Ca2+ too slowly to participate in the regulation of contraction.17 However, under conditions of sustained elevations in intracellular Ca2+, the site could bind Ca2+ and in this way buffer Ca2+ and/or regulate myosin function. Such binding could plausibly be important in myofibrillogenesis, since it is well established that spontaneous Ca2+ transients occur during embryonic development of striated muscles.18,19Similar Outcomes Caused by Mutations/Deletions of Other Myofibrillar ProteinsAlthough the mechanism by which deletion of MLC-2 disrupts thick filament assembly and myofibrillogenesis is not known, important clues could emerge from findings that other myofibrillar proteins are important in the process. As Rottbauer et al3 point out, zebrafish lacking titin20 display abnormalities similar to deletion of MLC-2, and mice lacking the atrial isoform of MLC-2 exhibit disruption of myofibrillar organization in the atria.21Previous work has also shown that phosphorylation of MLC-2 is important in development, as inhibition of myosin light chain kinase disrupts thick filament assembly in embryonic myocytes in culture.19 Thus, when Ca2+ increases during development, myosin light-chain kinase is activated and MLC-2 is phosphorylated and contributes critically to thick filament assembly.19,22Thus, Rottbauer et al have shown that MLC-2 plays an essential role in the assembly of cardiac thick filament and the sarcomere, but whether this is because of a structural or contractile effect of MLC-2 is presently unknown. Either way, MLC-2 is emerging as an important element in the constellation of factors that affect cardiac function in health and disease.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.Source of FundingThe authors acknowledge NIH grant number HL 82900.DisclosuresNone.FootnotesCorrespondence to Dr Richard L. Moss, Department of Physiology, University of Wisconsin Medical School, 1300 University Ave, Madison, WI 53706. E-mail [email protected] References 1 Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Ann Rev Physiol. 2005; 67: 39–67.CrossrefMedlineGoogle Scholar2 Walker JW. Protein kinase C, troponin I and heart failure: overexpressed, hyperphosphorylated and underappreciated? J Mol Cell Cardiol. 2006; 40: 446–450.CrossrefMedlineGoogle Scholar3 Rottbauer W, Wessels G, Dahme T, Just S, Trano N, Hassel D, Burns CG, Katus HA, Fishman MC. Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart. Circ Res. 2006; 99: 323–331.LinkGoogle Scholar4 Poetter K, Jiang H, Hassanzedah S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genetics. 1996; 13: 63–69.CrossrefMedlineGoogle Scholar5 Davis JA, Hassanzadeh S, Winitsky S, Lin H, Satorius C, Vemuri R, Aletras AH, Wen H, Epstein ND. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell. 2001; 107: 631–641.CrossrefMedlineGoogle Scholar6 Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev. 1996; 76: 371–423.CrossrefMedlineGoogle Scholar7 Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001; 104: 557–567.CrossrefMedlineGoogle Scholar8 Epstein ND, Davis JS. When is a fly in the ointment a solution and not a problem? Circ Res. 2006; 98: 1212–1218.LinkGoogle Scholar9 Moss RL, Razumova M, Fitzsimons DP. Myosin crossbridge activation of cardiac thin filaments: implications for myocardial function in health and disease. Circ Res. 2004; 94: 1290–1300.LinkGoogle Scholar10 Campbell K. Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics. Biophy J. 1997; 72: 254–262.CrossrefMedlineGoogle Scholar11 Soderling TR, Stull JT. Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev. 2001; 101: 2341–2352.CrossrefMedlineGoogle Scholar12 Olsson MC, Patel JR, Fitzsimons DP, Walker JW, Moss RL. Basal myosin light chain phosphorylation is a determinant of Ca2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am J Physiol. 2004; 287: H2712–H2718.CrossrefMedlineGoogle Scholar13 Patel JR, Diffee GM, Huang XP, Moss RL. Phosphorylation of myosin regulatory light chain eliminates force-dependent changes in relaxation rates in skeletal muscle. Biophys J. 1998; 74: 360–368.CrossrefMedlineGoogle Scholar14 Levine RJC, Kensler RW, Yang Z, Stull JT, Sweeney HL. Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophys J. 1996; 71: 898–907.CrossrefMedlineGoogle Scholar15 Stelzer JE, Larsson L, Fitzsimons DP, Moss RL. Activation dependence of stretch activation in mouse skinned myocardium: implications for ventricular function. J Gen Physiol. 2006; 127: 95–107.CrossrefMedlineGoogle Scholar16 Chen J, Kubalak SW, Minamisawa S, Price RL, Becker KD, Hickey R, Ross J, Chien KR. Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem. 1998; 273: 1252–1256.CrossrefMedlineGoogle Scholar17 Holroyde MJ, Potter JD, Solaro RJ. The calcium binding properties of phosphorylated and unphosphorylated cardiac and skeletal myosins. J Biol Chem. 1979; 254: 6478–6482.CrossrefMedlineGoogle Scholar18 Flucher BE, Andrews SB. Characterization of spontaneous and action potential-induced calcium transients in developing myotubes in vivo. Cell Motil Cytoskel. 1993; 25: 143–157.CrossrefMedlineGoogle Scholar19 Li H, Cook JD, Terry M, Spitzer NC, Ferrari MB. Calcium transients regulate patterned actin assembly during myofibrillogenesis. Dev Dyn. 2004; 229: 231–242.CrossrefMedlineGoogle Scholar20 Xu X, Meiler SE, Zhong TP, Mohideen M, Crossley DA, Burggren WW, Fishman MC. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nature Genetics. 2002; 30: 205–209.CrossrefMedlineGoogle Scholar21 Huang C, Sheikh F, Hollander M, Cai C, Becker D, Chu PH, Evans S, Chen J. Embryonic atrial function is essential for mouse embryogenesis, cardiac morphogenesis and angiogenesis. Development. 2003; 130: 6111–6119.CrossrefMedlineGoogle Scholar22 Aoki H, Sadoshima J, Izumo S. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat Med. 2000; 6: 183–188.CrossrefMedlineGoogle Scholar23 Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick DR, Benning MM, Winkelmann DA, Wesenberg G, Holden HM. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 1993; 261: 50–58.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited ByHitsumoto T, Tsukamoto O, Matsuoka K, Li J, Liu L, Kuramoto Y, Higo S, Ogawa S, Fujino N, Yoshida S, Kioka H, Kato H, Hakui H, Saito Y, Okamoto C, Inoue H, Hyejin J, Ueda K, Segawa T, Nishimura S, Asano Y, Asanuma H, Tani A, Imamura R, Komagawa S, Kanai T, Takamura M, Sakata Y, Kitakaze M, Haruta J and Takashima S (2023) Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin, Circulation, 147:25, (1902-1918), Online publication date: 20-Jun-2023. Hu Z, Cao J, Zhang J, Ge L, Zhang H and Liu X (2021) Skeletal Muscle Transcriptome Analysis of Hanzhong Ma Duck at Different Growth Stages Using RNA-Seq, Biomolecules, 10.3390/biom11020315, 11:2, (315) Upadhyay S, Gupta K, Mantha A and Dhiman M (2020) A short review: Doxorubicin and its effect on cardiac proteins, Journal of Cellular Biochemistry, 10.1002/jcb.29840, 122:2, (153-165), Online publication date: 1-Feb-2021. F. Wieczorek D (2019) The Role of Tropomyosin in Cardiac Function and Disease Cardiac Diseases and Interventions in 21st Century, 10.5772/intechopen.81420 X. Cai L, Tanada Y, D. Bello G, C. Fleming J, F. Alkassis F, Ladd T, Golde T, Koh J, Chen S and Kasahara H (2019) Cardiac MLC2 kinase is localized to the Z-disc and interacts with α-actinin2, Scientific Reports, 10.1038/s41598-019-48884-w, 9:1 Tougas C, Grindrod T, Cai L, Alkassis F and Kasahara H (2019) Heterozygous Mylk3 Knockout Mice Partially Recapitulate Human DCM With Heterozygous MYLK3 Mutations, Frontiers in Physiology, 10.3389/fphys.2019.00696, 10 Hu S, Cheng M, Guo X, Wang S, Liu B, Jiang H, Huang C and Wu G (2019) Down‐regulation of miR‐200c attenuates AngII‐induced cardiac hypertrophy via targeting the MLCK‐mediated pathway, Journal of Cellular and Molecular Medicine, 10.1111/jcmm.14135, 23:4, (2505-2516), Online publication date: 1-Apr-2019. Tamargo J, Caballero R and Delpón E (2018) New drugs in preclinical and early stage clinical development in the treatment of heart failure, Expert Opinion on Investigational Drugs, 10.1080/13543784.2019.1551357, 28:1, (51-71), Online publication date: 2-Jan-2019. Abdullah A, Eyster K, Bjordahl T, Xiao P, Zeng E and Wang X (2017) Murine Myocardial Transcriptome Analysis Reveals a Critical Role of COPS8 in the Gene Expression of Cullin-RING Ligase Substrate Receptors and Redox and Vesicle Trafficking Pathways, Frontiers in Physiology, 10.3389/fphys.2017.00594, 8 Chung J, Biesiadecki B, Ziolo M, Davis J and Janssen P (2016) Myofilament Calcium Sensitivity: Role in Regulation of In vivo Cardiac Contraction and Relaxation, Frontiers in Physiology, 10.3389/fphys.2016.00562, 7 Islam Y, Joseph R, Chowdhury R, Anderson R and Kasahara H (2016) Heart Failure Induced by Perinatal Ablation of Cardiac Myosin Light Chain Kinase, Frontiers in Physiology, 10.3389/fphys.2016.00480, 7 Massengill M, Ashraf H, Chowdhury R, Chrzanowski S, Kar J, Warren S, Walter G, Zeng H, Kang B, Anderson R, Moss R and Kasahara H (2016) Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase, Cardiovascular Research, 10.1093/cvr/cvw069, 111:1, (34-43), Online publication date: 1-Jul-2016. Scheid L, Mosqueira M, Hein S, Kossack M, Juergensen L, Mueller M, Meder B, Fink R, Katus H and Hassel D (2016) Essential light chain S195 phosphorylation is required for cardiac adaptation under physical stress, Cardiovascular Research, 10.1093/cvr/cvw066, 111:1, (44-55), Online publication date: 1-Jul-2016. Zile M and Trayanova N (2016) Rate-dependent force, intracellular calcium, and action potential voltage alternans are modulated by sarcomere length and heart failure induced-remodeling of thin filament regulation in human heart failure: A myocyte modeling study, Progress in Biophysics and Molecular Biology, 10.1016/j.pbiomolbio.2015.12.012, 120:1-3, (270-280), Online publication date: 1-Jan-2016. Tarigopula M, Davis R, Mungai P, Ryba D, Wieczorek D, Cowan C, Violin J, Wolska B and Solaro R (2015) Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model, Cardiovascular Research, 10.1093/cvr/cvv162, 107:2, (226-234), Online publication date: 15-Jul-2015. Zhang Y, Liu B, Luo X, Li T, Zhang J, Peng J, Zhang X, Ma Q, Hu C, Li Y, Peng J and Li Q (2015) Nuclear cardiac myosin light chain 2 modulates NADPH oxidase 2 expression in myocardium: a novel function beyond muscle contraction, Basic Research in Cardiology, 10.1007/s00395-015-0494-5, 110:4, Online publication date: 1-Jul-2015. Peng Y, Gregorich Z, Valeja S, Zhang H, Cai W, Chen Y, Guner H, Chen A, Schwahn D, Hacker T, Liu X and Ge Y (2014) Top-down Proteomics Reveals Concerted Reductions in Myofilament and Z-disc Protein Phosphorylation after Acute Myocardial Infarction, Molecular & Cellular Proteomics, 10.1074/mcp.M114.040675, 13:10, (2752-2764), Online publication date: 1-Oct-2014. Peng Y, Ayaz-Guner S, Yu D and Ge Y (2014) Top-down mass spectrometry of cardiac myofilament proteins in health and disease, PROTEOMICS - Clinical Applications, 10.1002/prca.201400043, 8:7-8, (554-568), Online publication date: 1-Aug-2014. England J and Loughna S (2012) Heavy and light roles: myosin in the morphogenesis of the heart, Cellular and Molecular Life Sciences, 10.1007/s00018-012-1131-1, 70:7, (1221-1239), Online publication date: 1-Apr-2013. Taylor P, Clark A, Marsh A, Singer D and Dilly S (2013) A chemical genomics approach to identification of interactions between bioactive molecules and alternative reading frame proteins, Chemical Communications, 10.1039/c3cc44647f, 49:83, (9588), . Schulz E, Correll R, Sheikh H, Lofrano-Alves M, Engel P, Newman G, Schultz J, Molkentin J, Wolska B, Solaro R and Wieczorek D (2012) Tropomyosin Dephosphorylation Results in Compensated Cardiac Hypertrophy, Journal of Biological Chemistry, 10.1074/jbc.M112.402040, 287:53, (44478-44489), Online publication date: 1-Dec-2012. Hammer E, Phong T, Steil L, Klingel K, Salazar M, Bernhardt J, Kandolf R, Kroemer H, Felix S and Völker U (2010) Viral myocarditis induced by Coxsackievirus B3 in A.BY / SnJ mice: Analysis of changes in the myocardial proteome , PROTEOMICS, 10.1002/pmic.200900734, 10:9, (1802-1818), Online publication date: 1-May-2010. Cieniewski-Bernard C, Montel V, Stevens L and Bastide B (2010) O-GlcNAcylation, an original modulator of contractile activity in striated muscle, Journal of Muscle Research and Cell Motility, 10.1007/s10974-010-9201-1, 30:7-8, (281-287), Online publication date: 1-Dec-2009. Park K and Kwak I (2009) Calponin gene expression in Chironomus riparius exposed to di(2-ethylhexyl) phthalate , Environmental Toxicology, 10.1002/tox.20463, 24:6, (555-562), Online publication date: 1-Dec-2009. Li Q and Sarna S (2009) Nuclear Myosin II Regulates the Assembly of Preinitiation Complex for ICAM-1 Gene Transcription, Gastroenterology, 10.1053/j.gastro.2009.03.040, 137:3, (1051-1060.e3), Online publication date: 1-Sep-2009. Swartz D, Greaser M and Cantino M (2009) Muscle Structure and Function Applied Muscle Biology and Meat Science, 10.1201/b15797-2, (1-45), Online publication date: 26-May-2009. Solaro R (2008) Multiplex Kinase Signaling Modifies Cardiac Function at the Level of Sarcomeric Proteins, Journal of Biological Chemistry, 10.1074/jbc.R800037200, 283:40, (26829-26833), Online publication date: 1-Oct-2008. Huang J, Shelton J, Richardson J, Kamm K and Stull J (2008) Myosin Regulatory Light Chain Phosphorylation Attenuates Cardiac Hypertrophy, Journal of Biological Chemistry, 10.1074/jbc.M802605200, 283:28, (19748-19756), Online publication date: 1-Jul-2008. Yuan C and Solaro R (2008) Myofilament proteins: From cardiac disorders to proteomic changes, PROTEOMICS – CLINICAL APPLICATIONS, 10.1002/prca.200780076, 2:6, (788-799), Online publication date: 1-Jun-2008. Chan J, Takeda M, Briggs L, Graham M, Lu J, Horikoshi N, Weinberg E, Aoki H, Sato N, Chien K and Kasahara H (2008) Identification of Cardiac-Specific Myosin Light Chain Kinase, Circulation Research, 102:5, (571-580), Online publication date: 14-Mar-2008. Ilancheran S, Michalska A, Peh G, Wallace E, Pera M and Manuelpillai U (2007) Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential, Biology of Reproduction, 10.1095/biolreprod.106.055244, 77:3, (577-588), Online publication date: 1-Sep-2007. Palpant N, Yasuda S, MacDougald O and Metzger J (2007) Non-canonical Wnt signaling enhances differentiation of Sca1+/c-kit+ adipose-derived murine stromal vascular cells into spontaneously beating cardiac myocytes, Journal of Molecular and Cellular Cardiology, 10.1016/j.yjmcc.2007.06.012, 43:3, (362-370), Online publication date: 1-Sep-2007. August 4, 2006Vol 99, Issue 3 Advertisement Article InformationMetrics https://doi.org/10.1161/01.RES.0000236793.88131.dcPMID: 16888245 Originally publishedAugust 4, 2006 Keywordsthick filamentmyosin light chain 2developmentPDF download Advertisement